抗念珠菌药物的耐药特性分析

被引:5
作者
曾昭瑛
苏建荣
机构
[1] 首都医科大学附属北京友谊医院临床检验中心
关键词
真菌感染; 念珠菌; 药物敏感性试验; 耐药性;
D O I
暂无
中图分类号
R446.5 [微生物学检验];
学科分类号
100208 ;
摘要
真菌侵袭性感染日益增多,抗真菌药大量应用导致念珠菌耐药菌株相继出现。本文旨在介绍抗念珠菌药物的特点、药物敏感性试验方法和要求、国内外耐药现状及念珠菌感染治疗选药推荐等内容。
引用
收藏
页码:169 / 176
页数:8
相关论文
共 46 条
[1]  
Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. Chandra J,Kuhn DM,Mukherjee PK,et al. Journal of Bacteriology . 2001
[2]   Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis [J].
Heimark, L ;
Shipkova, P ;
Greene, J ;
Munayyer, H ;
Yarosh-Tomaine, T ;
DiDomenico, B ;
Hare, R ;
Pramanik, BN .
JOURNAL OF MASS SPECTROMETRY, 2002, 37 (03) :265-269
[3]  
Major role for amphotericin B-flucytosine combination in severe cryptococcosis. Dromer F,Bernede-Bauduin C,Guillemot D, et al. PloS ONE . 2008
[4]  
Nonsense andmissense mutations in FCY2 and FCY1 genes are responsi-ble for flucytosine resistance and flucytosine-fluconazolecross-resistance in clinical isolates of Candida lusitaniae. Florent M,Nol T,Ruprich-Robert G,et al. Antimicrobial Agents and Chemotherapy . 2009
[5]  
Mutational analysis of flucytosineresistance in Candida glabrata. Edlind T D,Katiyar S K. Antimicrobial Agents and Chemotherapy . 2010
[6]  
Fluconazole for the management of invasive candidiasis:where do we stand after15years. Charlier C,Hart E,Lefort A,et al. Journal of Antimicrobial Chemotherapy . 2006
[7]  
Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis. Hope WW,Warn PA,Sharp A, et al. The Journal of Infectious Diseases . 2005
[8]  
Functionalcharacterization of the Chlamydomonas reinhardtii ERG3 or-tholog,a gene involved in the biosynthesis of ergosterol. Brumfield K M,Moroney J V,Moore T S,et al. PLoS One . 2010
[9]  
Identification andcharacterization of four azole-resistant erg3 mutants of Can-dida albicans. Martel C M,Parker J E,Bader O,et al. Antimicrobial Agents and Chemotherapy . 2010
[10]  
Overexpression of Candi-da albicans CDR1,CDR2,or MDR1 does not produce sig-nificant changes in echinocandin susceptibility. Niimi K,Maki K,Ikeda F,et al. Antimicrobial Agents and Chemotherapy . 2006